|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,020.00 JPY | -1.18% |
|
+2.12% | +3.83% |
| Capitalization | 8,024B 50.76B 43.46B 40.42B 37.68B 70.41B 4,575B 75.52B 466B 183B 2,189B 190B 186B | P/E ratio 2026 * |
41.9x | P/E ratio 2027 * | 27.3x |
|---|---|---|---|---|---|
| Enterprise value | 11,914B 75.36B 64.53B 60.01B 55.95B 105B 6,792B 112B 691B 272B 3,249B 283B 277B | EV / Sales 2026 * |
2.63x | EV / Sales 2027 * | 2.56x |
| Free-Float |
99.61% | Yield 2026 * |
3.94% | Yield 2027 * | 4% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | -1.18% | ||
| 1 week | +2.12% | ||
| Current month | +3.83% | ||
| 1 month | +12.86% | ||
| 3 months | +18.73% | ||
| 6 months | +15.11% | ||
| Current year | +3.83% |
| 1 week | 4,863 |  | 5,153 |
| 1 month | 4,468 | | 5,153 |
| Current year | 4,863 | | 5,153 |
| 1 year | 3,916 | | 5,153 |
| 3 years | 3,852 | | 5,153 |
| 5 years | 2,993 | | 5,153 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 59 | 01/04/2015 |
Milano Furuta
DFI | Director of Finance/CFO | - | 01/04/2024 |
Mwana Lugogo
CMP | Compliance Officer | 56 | 01/01/2012 |
| Director | Title | Age | Since |
|---|---|---|---|
Christophe Weber
BRD | Director/Board Member | 59 | 01/06/2014 |
Andrew Plump
BRD | Director/Board Member | 60 | 01/06/2015 |
| Director/Board Member | 73 | 01/06/2016 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +4.14% | 24.44% | 27 M€ | |
| +6.16% | 5% | 476 M€ | |
| +5.49% | 3.8% | 2,393 M€ | |
| -30.99% | 3.43% | 4 M€ | |
| +6.28% | 3.26% | 120 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.18% | +2.12% | +21.82% | +22.59% | 50.76B | |
| +1.64% | +3.79% | +35.14% | +201.01% | 968B | |
| +2.61% | +2.65% | +47.63% | +20.53% | 505B | |
| -0.02% | -0.06% | +25.62% | +44.55% | 389B | |
| -0.72% | +4.39% | +28.27% | +17.60% | 367B | |
| -0.96% | +4.50% | +29.24% | +22.17% | 295B | |
| -1.21% | +1.63% | +10.02% | -2.31% | 271B | |
| -0.12% | +4.70% | +25.12% | +35.05% | 274B | |
| +1.58% | +10.97% | -37.24% | -15.77% | 263B | |
| -0.17% | +1.50% | +24.14% | +20.16% | 175B | |
| Average | +0.05% | +3.95% | +20.98% | +36.56% | 355.89B | |
| Weighted average by Cap. | +0.18% | +3.73% | +25.90% | +68.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4,512B 28.54B 24.44B 22.73B 21.19B 39.59B 2,573B 42.47B 262B 103B 1,231B 107B 105B | 4,538B 28.71B 24.58B 22.86B 21.31B 39.82B 2,587B 42.71B 263B 104B 1,238B 108B 105B |
| Net income | 197B 1.24B 1.07B 991M 923M 1.73B 112B 1.85B 11.41B 4.49B 53.63B 4.66B 4.57B | 296B 1.87B 1.6B 1.49B 1.39B 2.59B 169B 2.78B 17.15B 6.74B 80.61B 7.01B 6.87B |
| Net Debt | 3,889B 24.6B 21.07B 19.59B 18.26B 34.13B 2,217B 36.6B 226B 88.71B 1,061B 92.26B 90.37B | 3,594B 22.73B 19.47B 18.1B 16.88B 31.54B 2,049B 33.83B 209B 81.98B 980B 85.26B 83.51B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/01/26 | 5,020.00 ¥ | -1.18% | 7,292,300 |
| 09/01/26 | 5,080.00 ¥ | -0.14% | 5,141,400 |
| 08/01/26 | 5,087.00 ¥ | +2.73% | 6,317,000 |
| 07/01/26 | 4,952.00 ¥ | +0.79% | 5,151,500 |
| 06/01/26 | 4,913.00 ¥ | -0.06% | 4,707,800 |
Delayed Quote Japan Exchange, January 13, 2026 at 02:30 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition